Li Wang, MD, PhD

MD Anderson Cancer Center
Houston, Texas

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 316 - The Preliminary Analysis of Circulating Human Papillomavirus DNA in a Phase III Trial of Concurrent Chemoradiation (CRT) with Intensity Modulated Proton Therapy (IMPT) vs. IMRT in Oropharyngeal Squamo

  Tuesday, October 1, 2024
  4:40 PM – 4:50 PM ET